logo
Select company
Select metric
$ -4.97MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
29
Sector
68
Industry
63
History
93
$ 0.91Close
$ 0.43 - $ 1.22 52-Week Range
Ticker Information

Ticker

NMTC

Company Name

NEUROONE MEDICAL TECHNOLOGIES CORP

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

NEUROONE MEDICAL TECHNOLOGIES CORP - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NMTC - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 371.59K$ -5.34M$ -4.97M
3/31/2025$ 368.35K$ -6.6M$ -6.24M
12/31/2024$ 365.47K$ -7.19M$ -6.82M
9/30/2024$ 360.32K$ -12.32M$ -11.96M
6/30/2024$ 360.05K$ -12.1M$ -11.74M
3/31/2024$ 353.31K$ -12.8M$ -12.45M
12/31/2023$ 333.95K$ -13.47M$ -13.14M
9/30/2023$ 309.1K$ -11.86M$ -11.55M
6/30/2023$ 279.32K$ -10.1M$ -9.82M
3/31/2023$ 253.3K$ -9.39M$ -9.14M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NEUROONE MEDICAL TECHNOLOGIES CORP's latest trailing twelve months (TTM) EBITDA stands at $ -6.05M.
  • Over the past 5 years, NEUROONE MEDICAL TECHNOLOGIES CORP's average EBITDA has been $ -9.29M.
  • The median EBITDA for NEUROONE MEDICAL TECHNOLOGIES CORP during this period was $ -9.79M
  • NEUROONE MEDICAL TECHNOLOGIES CORP reached its highest EBITDA over the past 5 years at $ -4.97M.
  • The lowest EBITDA recorded by NEUROONE MEDICAL TECHNOLOGIES CORP in the same timeframe $ -13.14M

NEUROONE MEDICAL TECHNOLOGIES CORP's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
VVOS : VIVOS THERAPEUTICS INC $ -13.55MMLSS : MILESTONE SCIENTIFIC INC $ -6.81MNUWE : NUWELLIS INC $ -3.84MMODD : MODULAR MEDICAL INC $ -19.74MVERU : VERU INC $ -31.9MHIND : VYOME HOLDINGS INC $ -4.43MXAIR : BEYOND AIR INC $ -35.84MIVF : INVO FERTILITY INC $ -26.06MCUE : CUE BIOPHARMA INC $ -36.06MBCAB : BIOATLA INC $ -58.76M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for NEUROONE MEDICAL TECHNOLOGIES CORP is calculated as follows: EBIT [ $ -6.12M ] + DepAmor [ $ 70.55K ]
(=) EBITDA [ $ -6.05M ]

NMTC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -13.14M

Minimum

Dec 31, 2023

$ -4.97M

Maximum

Jun 30, 2025

$ -9.29M

Average

$ -9.79M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.87M with a standard deviation of $ 166.99M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.87M
median$ 8.87M
std$ 166.99M